ViiV Healthcare

ViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (LSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with HIV and for people who are at risk of becoming infected with HIV. Shionogi joined in October 2012. The company's aim is to take a deeper and broader interest in HIV/AIDS than any company has done before and take a new approach to deliver effective and innovative medicines for HIV treatment and prevention, as well as support communities affected by HIV.

For more information on the company, its management, portfolio, pipeline and commitment, please visit www.viivhealthcare.com.

Health & Healthcare | ViiV Healthcare

ViiV Healthcare Announces Recipients of Largest Philanthropic Fund in the US Dedicated to HIV Prevention for Black Women

Oct 7, 2022 8:00 AM ET

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced the recipients of an $8 million investment to increase awareness and action around HIV prevention and

Flexible Media Releases

ViiV Healthcare Announces Recipients of Largest Philanthropic Fund in the US Dedicated to HIV Prevention for Black Women

Oct 7, 2022 8:00 AM ET

ViiV Healthcare Announces Support for Community-Based Organizations With New Monkeypox Emergency Response Fund in the US

Aug 9, 2022 7:05 PM ET

ViiV Healthcare Builds on Accelerate Initiative, Extending Community-Centered Approach Nationally to Disrupt Disparities in Care for Black Same-Gender-Loving Men Living With HIV

Feb 25, 2021 1:00 PM ET